Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast

Radiology. 1997 Apr;203(1):145-9. doi: 10.1148/radiology.203.1.9122383.

Abstract

Purpose: To evaluate the influence of menstrual cycle and age on parenchymal contrast medium enhancement in magnetic resonance (MR) imaging of the breast.

Materials and methods: Dynamic gadolinium-enhanced fast low-angle shot, three-dimensional breast MR imaging was performed with high temporal and spatial resolution (eight measurements in 10 minutes). Menstrual cycle evaluations and age-influence studies were performed in 44 patients aged 27-55 years with a regular cycle (mean age, 41.5 years) and in 103 patients aged 15-79 years (mean age, 49.3 years), respectively. A region of interest was placed in each quadrant of the breast for evaluation of parenchymal enhancement. Quadrants with complete involution or lesions and patients who received hormonal therapy were excluded [corrected]. Analysis of variance was performed.

Results: Parenchymal contrast medium enhancement in cycle days 7-20 (geometric mean enhancement at minutes 1-10 = 0.12-0.47) was significantly lower than that in cycle days 21-6 (geometric mean, 0.17-0.98; P < or = .001). Contrast medium enhancement in patients aged 35-50 years (mean enhancement, 0.17-0.75) was significantly higher than that in patients aged younger than 35 years or older than 50 years (mean enhancement, 0.12-0.40; P < .01).

Conclusion: Patients showed statistically significantly lower parenchymal enhancement in menstrual cycle days 7-20 than in days 21-6. Patients aged 35-50 years yielded higher parenchymal enhancement than did younger patients and older patients.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aging*
  • Breast / anatomy & histology*
  • Contrast Media*
  • Drug Combinations
  • Female
  • Gadolinium
  • Gadolinium DTPA
  • Humans
  • Magnetic Resonance Imaging*
  • Meglumine
  • Menstrual Cycle*
  • Middle Aged
  • Organometallic Compounds
  • Pentetic Acid / analogs & derivatives

Substances

  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA